An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder. [PDF]
Medicine (Baltimore)Bai WZ, Zhou SY, Mou YY, Peng L, Li LL.
europepmc +1 more source
Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation. [PDF]
World J Surg OncolLin M, Chen X, Lin F, Yang Y.
europepmc +1 more source
Scaffold-Hopping Design and Synthesis of Thieno[3,2-<i>d</i>]pyrimidines: Anticancer Activity, Apoptosis Induction, and In Silico Inhibition of CDKs. [PDF]
Int J Mol SciRuzi Z +9 more
europepmc +1 more source
Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation. [PDF]
Intern MedYoshida J +13 more
europepmc +1 more source
Targeting MET and KRAS G12C co-occurring mutation in metastatic adenoid cystic carcinoma of the trachea: a case report. [PDF]
J Med Case RepZhang L, Wang T, Xu Y, Ji Y, Nie K.
europepmc +1 more source
Trametinib-induced Hyponatremia in a Patient With Craniopharyngioma and Diabetes Insipidus. [PDF]
J Pediatr Hematol OncolGunasekara B +4 more
europepmc +1 more source